POET TECHNOLOGIES INC (POET)

CA73044W3021 - Common Stock

6.75  +0.58 (+9.4%)

After market: 6.8299 +0.08 (+1.18%)

Fundamental Rating

2

POET gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 108 industry peers in the Semiconductors & Semiconductor Equipment industry. The financial health of POET is average, but there are quite some concerns on its profitability. POET has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

In the past year POET has reported negative net income.
POET had a negative operating cash flow in the past year.
POET had negative earnings in each of the past 5 years.
POET had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -63.17%, POET is doing worse than 91.59% of the companies in the same industry.
Looking at the Return On Equity, with a value of -104.21%, POET is doing worse than 85.05% of the companies in the same industry.
Industry RankSector Rank
ROA -63.17%
ROE -104.21%
ROIC N/A
ROA(3y)-141.78%
ROA(5y)-121.23%
ROE(3y)-219.16%
ROE(5y)-200.3%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

POET does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

POET does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, POET has more shares outstanding
POET has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, POET has a worse debt to assets ratio.

2.2 Solvency

POET has an Altman-Z score of 6.89. This indicates that POET is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 6.89, POET is doing good in the industry, outperforming 67.29% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that POET is not too dependend on debt financing.
The Debt to Equity ratio of POET (0.01) is better than 66.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 6.89
ROIC/WACCN/A
WACC13.03%

2.3 Liquidity

A Current Ratio of 2.20 indicates that POET has no problem at all paying its short term obligations.
POET has a worse Current ratio (2.20) than 68.22% of its industry peers.
A Quick Ratio of 2.20 indicates that POET has no problem at all paying its short term obligations.
POET has a Quick ratio of 2.20. This is comparable to the rest of the industry: POET outperforms 51.40% of its industry peers.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 2.2

3

3. Growth

3.1 Past

POET shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.46%.
The Revenue for POET has decreased by -78.58% in the past year. This is quite bad
EPS 1Y (TTM)-13.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.85%
Revenue 1Y (TTM)-78.58%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 22.09% on average over the next years. This is a very strong growth
POET is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 290.49% yearly.
EPS Next Y17%
EPS Next 2Y19.16%
EPS Next 3Y22.09%
EPS Next 5YN/A
Revenue Next Year-89.98%
Revenue Next 2Y214.13%
Revenue Next 3Y327.29%
Revenue Next 5Y290.49%

3.3 Evolution

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for POET. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for POET. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as POET's earnings are expected to grow with 22.09% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.16%
EPS Next 3Y22.09%

0

5. Dividend

5.1 Amount

No dividends for POET!.
Industry RankSector Rank
Dividend Yield N/A

POET TECHNOLOGIES INC

NASDAQ:POET (1/3/2025, 8:00:01 PM)

After market: 6.8299 +0.08 (+1.18%)

6.75

+0.58 (+9.4%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)N/A N/A
Inst Owners5.24%
Inst Owner Change73.66%
Ins Owners0.76%
Ins Owner ChangeN/A
Market Cap516.24M
Analysts82.5
Price Target6.08 (-9.93%)
Short Float %4.6%
Short Ratio1.59
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-91.59%
Min EPS beat(2)-130.68%
Max EPS beat(2)-52.51%
EPS beat(4)0
Avg EPS beat(4)-52.91%
Min EPS beat(4)-130.68%
Max EPS beat(4)-10.83%
EPS beat(8)3
Avg EPS beat(8)-25.69%
EPS beat(12)5
Avg EPS beat(12)-17.32%
EPS beat(16)8
Avg EPS beat(16)-15.47%
Revenue beat(2)0
Avg Revenue beat(2)-96.73%
Min Revenue beat(2)-100%
Max Revenue beat(2)-93.46%
Revenue beat(4)1
Avg Revenue beat(4)-45.16%
Min Revenue beat(4)-100%
Max Revenue beat(4)111.77%
Revenue beat(8)1
Avg Revenue beat(8)-38.36%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)20.7%
PT rev (3m)7.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)30%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-88.89%
Revenue NY rev (1m)-62.45%
Revenue NY rev (3m)-92.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4303.79
P/FCF N/A
P/OCF N/A
P/B 16.86
P/tB 17.18
EV/EBITDA N/A
EPS(TTM)-0.59
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS0
BVpS0.4
TBVpS0.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -63.17%
ROE -104.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-141.78%
ROA(5y)-121.23%
ROE(3y)-219.16%
ROE(5y)-200.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 147.79%
Cap/Sales 2522.25%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.2
Quick Ratio 2.2
Altman-Z 6.89
F-Score3
WACC13.03%
ROIC/WACCN/A
Cap/Depr(3y)129.14%
Cap/Depr(5y)158.27%
Cap/Sales(3y)422.93%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.85%
EPS Next Y17%
EPS Next 2Y19.16%
EPS Next 3Y22.09%
EPS Next 5YN/A
Revenue 1Y (TTM)-78.58%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-89.98%
Revenue Next 2Y214.13%
Revenue Next 3Y327.29%
Revenue Next 5Y290.49%
EBIT growth 1Y-12.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year38.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-42.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.98%
OCF growth 3YN/A
OCF growth 5YN/A